EP Patent

EP0189861A3 — Percutaneous absorption accelerator for ionic water-soluble medicine

Assigned to Resonac Holdings Corp · Expires 1988-02-17 · 38y expired

What this patent protects

A percutaneous absorption accelerator for ionic water-­ soluble medicines comprising at least one member selected from the group consisting of ionic oil-soluble substances and their salts, amphoteric surfactants, and nonionic substances. These substances can effectively and ef…

USPTO Abstract

A percutaneous absorption accelerator for ionic water-­ soluble medicines comprising at least one member selected from the group consisting of ionic oil-soluble substances and their salts, amphoteric surfactants, and nonionic substances. These substances can effectively and efficiently accelerate the desired percutaneous absorption of ionic water-soluble medicines.

Drugs covered by this patent

Patent Metadata

Patent number
EP0189861A3
Jurisdiction
EP
Classification
—
Expires
1988-02-17
Drug substance claim
No
Drug product claim
No
Assignee
Resonac Holdings Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.